📊 MWAI Key Takeaways
Is MedWellAI, Inc. (MWAI) a Good Investment?
MedWellAI is technically insolvent with negative stockholders' equity of -$7.5M and a fundamentally broken business model evidenced by -65.4% gross margin. The company is burning cash at -$255.7K annually with critically poor liquidity (0.02x current ratio) and lacks any viable path to profitability without severe restructuring or capital injection.
Fundamentals indicate unsustainable unit economics (negative gross margin) and acute liquidity stress (current ratio 0.02x) with deep negative equity, signaling elevated going‑concern risk. With a small revenue base and ongoing operating and free cash flow losses, the business lacks capacity to self‑fund and will likely require dilutive financing or restructuring. Until gross margins turn positive and the balance sheet is repaired, risk outweighs potential upside.
Why Buy MedWellAI, Inc. Stock? MWAI Key Strengths
- Still maintaining minimal cash reserves of $137.5K
- Modest asset base of $460.9K reduces absolute downside exposure
- Low revenue base provides theoretical capacity for growth if business model corrects
- Asset‑light model with minimal capex needs
- Existing revenue base indicates some customer traction
- Potential operating leverage if unit economics are fixed
MWAI Stock Risks: MedWellAI, Inc. Investment Risks
- Negative stockholders' equity of -$7.5M indicates technical insolvency
- Negative gross margin of -65.4% proves business model is fundamentally unviable
- Severe cash burn of -$255.7K annually with only $137.5K cash remaining
- Critically impaired liquidity: 0.02x current ratio indicates inability to meet short-term obligations
- Debt burden of $328.0K unsustainable relative to assets and cash generation
- No insider activity in 90 days suggests lack of management confidence
- Immediate liquidity and going‑concern risk (negative equity, 0.02x current ratio)
- Unsustainably negative gross margin undermines scalability
- High leverage and poor interest coverage, implying default/dilution risk
Key Metrics to Watch
- Gross margin trajectory - must turn positive to validate business viability
- Operating cash flow - must cease negative cash burn immediately
- Stockholders' equity - must return to positive territory
- Current ratio and liquidity position - critical to assess solvency risk
- Gross margin
- Operating cash flow (quarterly)
MedWellAI, Inc. (MWAI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
MWAI Profit Margin, ROE & Profitability Analysis
MWAI vs Finance Sector: How MedWellAI, Inc. Compares
How MedWellAI, Inc. compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is MedWellAI, Inc. Stock Overvalued? MWAI Valuation Analysis 2026
Based on fundamental analysis, MedWellAI, Inc. has mixed fundamental signals relative to the Finance sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
MedWellAI, Inc. Balance Sheet: MWAI Debt, Cash & Liquidity
MWAI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: MedWellAI, Inc.'s revenue has declined by 68% over the 5-year period, indicating business contraction. The most recent EPS of $-11.98 indicates the company is currently unprofitable.
MWAI Revenue Growth, EPS Growth & YoY Performance
MWAI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $142.9K | -$287.5K | N/A |
| Q1 2026 | $1.1K | -$651.9K | N/A |
| Q3 2025 | $281.3K | $297.3K | $0.01 |
| Q2 2025 | $142.9K | -$359.6K | $-0.13 |
| Q1 2025 | $1.1K | -$1.2M | N/A |
| Q3 2024 | $1.5M | $297.3K | $0.01 |
| Q2 2024 | $370.3K | -$354.3K | $-0.13 |
| Q1 2024 | $555.4K | -$786.4K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
MedWellAI, Inc. Dividends, Buybacks & Capital Allocation
MWAI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for MedWellAI, Inc. (CIK: 0001520118)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MWAI
What is the AI rating for MWAI?
MedWellAI, Inc. (MWAI) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MWAI's key strengths?
Claude: Still maintaining minimal cash reserves of $137.5K. Modest asset base of $460.9K reduces absolute downside exposure. ChatGPT: Asset‑light model with minimal capex needs. Existing revenue base indicates some customer traction.
What are the risks of investing in MWAI?
Claude: Negative stockholders' equity of -$7.5M indicates technical insolvency. Negative gross margin of -65.4% proves business model is fundamentally unviable. ChatGPT: Immediate liquidity and going‑concern risk (negative equity, 0.02x current ratio). Unsustainably negative gross margin undermines scalability.
What is MWAI's revenue and growth?
MedWellAI, Inc. reported revenue of $1.1M.
Does MWAI pay dividends?
MedWellAI, Inc. pays dividends, with $0.3M distributed to shareholders in the trailing twelve months.
Where can I find MWAI SEC filings?
Official SEC filings for MedWellAI, Inc. (CIK: 0001520118) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MWAI's EPS?
MedWellAI, Inc. has a diluted EPS of $-0.45.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is MWAI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, MedWellAI, Inc. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is MWAI stock overvalued or undervalued?
Valuation metrics for MWAI: ROE of N/A (sector avg: 12%), net margin of -87.3% (sector avg: 25%). Compare these metrics with sector averages to assess valuation.
Should I buy MWAI stock in 2026?
Our dual AI analysis gives MedWellAI, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MWAI's free cash flow?
MedWellAI, Inc.'s operating cash flow is $-255.7K, with capital expenditures of $0.0. FCF margin is -23.8%.
How does MWAI compare to other Finance stocks?
Vs Finance sector averages: Net margin -87.3% (avg: 25%), ROE N/A (avg: 12%), current ratio 0.02 (avg: 1.2).